MX2016003327A - Composicion farmaceutica de citrato de sildenafilo en forma de suspension para uso oral. - Google Patents
Composicion farmaceutica de citrato de sildenafilo en forma de suspension para uso oral.Info
- Publication number
- MX2016003327A MX2016003327A MX2016003327A MX2016003327A MX2016003327A MX 2016003327 A MX2016003327 A MX 2016003327A MX 2016003327 A MX2016003327 A MX 2016003327A MX 2016003327 A MX2016003327 A MX 2016003327A MX 2016003327 A MX2016003327 A MX 2016003327A
- Authority
- MX
- Mexico
- Prior art keywords
- suspension
- sildenafil citrate
- pharmaceutical composition
- oral use
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica de citrato de sildenafilo en forma de suspensión para uso oral que comprende agua como vehículo y goma xantana e hipromelosa como agentes suspensores, que presenta una gran estabilidad y permite un eficaz enmascaramiento del sabor amargo del principio activo. También se refiere a un procedimiento para la preparación de dicha suspensión y a un envase que la contiene y que está provisto de un dispositivo dosificador para su administración. Esta composición de citrato de sildenafilo en forma de suspensión es adecuada para su administración por vía oral para el tratamiento de la disfunción sexual masculina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201500212A ES2584248B1 (es) | 2015-03-24 | 2015-03-24 | Composición farmacéutica de citrato de sildenafilo en forma de suspensión para uso oral |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2016003327A true MX2016003327A (es) | 2017-01-05 |
MX369760B MX369760B (es) | 2019-11-20 |
Family
ID=55646513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016003327A MX369760B (es) | 2015-03-24 | 2016-03-14 | Composición farmacéutica de citrato de sildenafilo en forma de suspensión para uso oral. |
Country Status (11)
Country | Link |
---|---|
US (1) | US10016428B2 (es) |
EP (1) | EP3072515B1 (es) |
AU (1) | AU2017265087B2 (es) |
CY (1) | CY1120282T1 (es) |
DK (1) | DK3072515T3 (es) |
ES (2) | ES2584248B1 (es) |
HR (1) | HRP20180819T1 (es) |
HU (1) | HUE037541T2 (es) |
MX (1) | MX369760B (es) |
PL (1) | PL3072515T3 (es) |
PT (1) | PT3072515T (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111683683A (zh) | 2017-12-26 | 2020-09-18 | Ftf药业私人有限公司 | Pde v抑制剂的液体口服制剂 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5759579A (en) * | 1996-12-05 | 1998-06-02 | American Home Products Corporation | Pharmaceutical suspension systems |
US20070087981A1 (en) * | 2002-02-08 | 2007-04-19 | Lavipharm Laboratories, Inc. | Water Soluble and Palatable Complexes |
US20060024335A1 (en) * | 2004-07-29 | 2006-02-02 | Roger Stier E | Oral compositions which mask the bitter taste of a bitter-tasting agent |
US20090047330A1 (en) * | 2007-08-17 | 2009-02-19 | Ramesh Bangalore | Oral fast dissolving films for erectile dysfunction bioactive agents |
CA2705453A1 (en) * | 2007-11-12 | 2009-05-11 | Novartis Ag | Pharmaceutical compositions |
US9907759B2 (en) * | 2011-02-11 | 2018-03-06 | Ctc Bio, Inc. | Sildenafil-free base-containing film preparation and method for producing same |
ES2475942B1 (es) * | 2013-01-11 | 2015-04-16 | Farmalider, S.A. | Composición farmacéutica de citrato de sildenafilo en forma de solución acuosa |
MX2013001279A (es) * | 2013-01-31 | 2013-08-26 | Miguel Angel Garcia Perez | Composicion farmaceutica con un inhibidor selectivo de la enzima fosfodiesterasa en forma de gel oral. |
-
2015
- 2015-03-24 ES ES201500212A patent/ES2584248B1/es not_active Expired - Fee Related
-
2016
- 2016-03-14 MX MX2016003327A patent/MX369760B/es active IP Right Grant
- 2016-03-15 DK DK16380008.9T patent/DK3072515T3/da active
- 2016-03-15 HU HUE16380008A patent/HUE037541T2/hu unknown
- 2016-03-15 PT PT163800089T patent/PT3072515T/pt unknown
- 2016-03-15 EP EP16380008.9A patent/EP3072515B1/en active Active
- 2016-03-15 PL PL16380008T patent/PL3072515T3/pl unknown
- 2016-03-15 ES ES16380008.9T patent/ES2671543T3/es active Active
- 2016-03-22 US US15/076,858 patent/US10016428B2/en active Active
-
2017
- 2017-11-23 AU AU2017265087A patent/AU2017265087B2/en active Active
-
2018
- 2018-05-24 HR HRP20180819TT patent/HRP20180819T1/hr unknown
- 2018-05-25 CY CY20181100569T patent/CY1120282T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US10016428B2 (en) | 2018-07-10 |
PL3072515T3 (pl) | 2018-12-31 |
HRP20180819T1 (hr) | 2018-07-13 |
DK3072515T3 (en) | 2020-01-06 |
AU2017265087A1 (en) | 2018-01-04 |
EP3072515A1 (en) | 2016-09-28 |
CY1120282T1 (el) | 2019-07-10 |
ES2584248B1 (es) | 2017-04-19 |
ES2584248A1 (es) | 2016-09-26 |
US20160279133A1 (en) | 2016-09-29 |
AU2017265087B2 (en) | 2018-11-01 |
PT3072515T (pt) | 2018-05-25 |
MX369760B (es) | 2019-11-20 |
HUE037541T2 (hu) | 2018-09-28 |
EP3072515B1 (en) | 2018-02-28 |
ES2671543T3 (es) | 2018-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017500479B1 (en) | Liquid inhalation formulation comprising rpl554 | |
MX2021013139A (es) | Composicion farmaceutica para la prevencion y/o tratamiento de dermatitis atopica que comprende antagonista de interleucina 31 (il-31) como ingrediente activo. | |
WO2014027975A3 (en) | Novel orally administered pharmaceutical formulations | |
WO2015120110A3 (en) | Novel pharmaceutical formulations | |
MX2016010179A (es) | Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer. | |
WO2018165404A8 (en) | Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol | |
NZ714963A (en) | Compositions and methods for treating anemia | |
MX2021002321A (es) | Nuevos metodos. | |
FI3666258T3 (fi) | Menetelmä prader-willin oireyhtymän hoitamiseksi | |
CA3010568A1 (en) | Oromucosal nanofiber carriers for therapeutic treatment | |
MA39765A (fr) | Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation | |
EP3162804A8 (en) | New benzodiazepine derivative and use thereof | |
MX2021002322A (es) | Nuevos metodos. | |
AR109093A1 (es) | Solución oral que comprende clorhidrato de atomoxetina y sus métodos | |
EA201892842A1 (ru) | Фармацевтические композиции, включающие сафинамид | |
MX2016003327A (es) | Composicion farmaceutica de citrato de sildenafilo en forma de suspension para uso oral. | |
PH12019501785A1 (en) | Intranasal composition comprising betahistine | |
MX2017015202A (es) | Formulaciones liquidas de celecoxib para administracion oral. | |
MX2020006900A (es) | Composición de ketamina en polvo seco para usarse en el tratamiento de depresión por medio de administración pulmonar. | |
ZA202200331B (en) | Naltrexone formulation | |
EA201891860A1 (ru) | Фармацевтическая композиция пролонгированного высвобождения, содержащая цистеамин или его соли | |
ZA202006986B (en) | Dantrolene formulations and methods of their use | |
MX2020005921A (es) | Formulaciones y metodos para el suministro vaginal de antiprogestinas. | |
PH12016502540A1 (en) | Pharmaceutical dosage forms | |
GR1008819B (el) | Φαρμακευτικο σκευασμα που περιλαμβανει ατομοξετινη και μεθοδος παρασκευης αυτου |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |